From: Elevated TNFRSF4 gene expression is a predictor of poor prognosis in non-M3 acute myeloid leukemia
Total | TNFRSF4 low (Z < 0) | TNFRSF4 high (Z ≥ 0) | p value | ||
---|---|---|---|---|---|
TNFRSF4 low vs. high | Fisher exact test | ||||
Sex, no. (%) | |||||
Female | 72 | 59 (81.9) | 13 (18.1) | 0.092 | |
Male | 85 | 78 (91.8) | 7 (8.2) | ||
Age, years (range) | 0.012 | ||||
Median | 59 | 57 | 66.5 | ||
Mean | 56.0 ± 1.29 | 54.9 ± 1.38 | 63.5 ± 3.24 | ||
WBC count ×109/L | 0.528 | ||||
Median | 22.2 | 22.2 | 25.95 | ||
Mean | 39.3 ± 3.76 | 37.0 ± 3.62 | 54.6 ± 15.93 | ||
PB blasts, % | 0.254 | ||||
Median | 72 | 71 | 76.5 | ||
Mean | 68.4 ± 1.51 | 67.7 ± 1.62 | 72.7 ± 4.13 | ||
BM blasts, % | 0.06 | ||||
Median | 42 | 39 | 58.5 | ||
Mean | 41.5 ± 2.58 | 39.5 ± 2.73 | 54.9 ± 7.32 | ||
NCCN subtype, no. | Vs. favorable | ||||
Favorable | 17 | 17 (100) | 0 (0) | ||
Intermediate | 92 | 82 (89.1) | 10 (10.9) | 0.169 | |
Poor | 45 | 36 (80) | 9 (20) | 0.044 | |
FAB subtype, no. | |||||
M0 | 16 | 13 | 3 | ||
M1 | 44 | 36 | 8 | ||
M2 | 38 | 33 | 5 | ||
M4 | 34 | 32 | 2 | ||
M5 | 18 | 17 | 1 | ||
M6 | 2 | 2 | 0 | ||
M7 | 3 | 2 | 1 |